Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where L. Jarolim is active.

Publication


Featured researches published by L. Jarolim.


European Urology | 2002

Qualitative and Quantitative Detection of Urinary Human Complement Factor H-Related Protein (BTA stat and BTA TRAK) and Fragments of Cytokeratins 8, 18 (UBC Rapid and UBC IRMA) as Markers for Transitional Cell Carcinoma of the Bladder

M. Babjuk; M Koštı́řová; K Mudra; S.M. Pecher; H Smolová; L Pecen; Z Ibrahim; Jan Dvořáček; L. Jarolim; J Novák; T Zima

OBJECTIVE To evaluate the role of BTA stat, BTA TRAK, UBC Rapid, UBC IRMA and voided urinary cytology in the detection of bladder transitional cell carcinoma (TCC). METHODS The study included 78 patients with TCC of the bladder (group A), 62 patients with a history of bladder TCC without tumor recurrence at the time of examination (B, control group), 20 patients with other malignancy of the urinary tract (C), 38 patients with non-malignant urinary tract diseases (D), 10 patients with urinary tract infection (E) and 10 healthy volunteers (F). Except in group F, voided urine was collected before cystoscopy or cystectomy. RESULTS The specificity and sensitivity in bladder cancer detection were 87.1 and 74.4%, respectively with BTA stat, 79.3 and 48.7%, respectively with UBC Rapid, 100 and 33.3%, respectively with cytology, 72.6 and 75.6%, respectively with BTA TRAK, 64.5 and 70.5%, respectively with UBC IRMA. CONCLUSIONS The BTA stat and BTATRAK tests are superior to UBC Rapid, UBC IRMA and urinary cytology in detection of bladder TCC. In daily practice however cytology remains the best adjunct to cystoscopy because of its high sensitivity in Tis and 100% specificity. Cystoscopy cannot be replaced by any of evaluated methods.


European Urology | 1997

Female urethra- sparing cystectomy and orthotopic bladder replacement

L. Jarolim; M. Babjuk; T. Hanus; Janský M; Skrivanová

OBJECTIVE Orthotopic bladder replacement after cystoprostatectomy has long become the method of choice in the treatment of infiltrating bladder cancer in males. Very good quality of life in patients thus treated stimulated the work on a similar approach applicable to females. METHODS Twelve females were treated by urethra-sparing cystectomy. The surgical technique preserves not just the urethra itself but also the pelvic floor and relevant innervation. RESULTS Diurnal continence was achieved in 11 patients, 1 of whom had a so-called hypercontinence with a residual volume of 300 ml. The remaining patient suffered from stress incontinence. CONCLUSION The described urethra-sparing radical cystectomy in female patients with a urothelial tumor, with normal pelvic floor and with a low risk of secondary affection of the urethra, permits reconstructing a continent orthotopic neobladder from a detubularized intestinal segment.


The Journal of Sexual Medicine | 2008

Clinical implications of a close vicinity of nervus dorsalis penis/clitoridis and os pubis.

Jiří Šedý; Ondřej Naňka; Jana Špačková; L. Jarolim

INTRODUCTION Close relation of nervus dorsalis penis/clitoris and os pubis has a major impact in surgical disciplines. AIM To summarize a current knowledge about this region, represented by the course of sulcus nervi dorsalis penis/clitoridis. METHODS Literature search of years 1970-2007. MAIN OUTCOME MEASURES In male, it accommodates nervus dorsalis penis whereas in female nervus et arteria dorsalis clitoridis. Lateral border of sulcus nervi dorsalis penis corresponds to vertical ridge and lateral border of sulcus nervi dorsalis clitoridis to ventral arc-two parameters, which are parts of the Phenices method for sexing of isolated os pubis. RESULTS Exact preparation of nervus dorsalis penis is crucial in correct performance of conversion of genitalia in patients with transsexualism, in reconstruction of posterior urethra, in hypospadia, during performance of penile blockade during circumcision and in revascularization surgery of erectile dysfunction. Possible role of the sulcus nervi dorsalis penis in the Alcocks syndrome is discussed. Similarly, it is advisable to take care of nervus dorsalis clitoridis during reduction clitoridoplasty in patients with adrenogenital syndrome and during the insertion of transobturator vaginal tape. Injury of nervus dorsalis penis/clitoridis leads to hypesthesia or anesthesia of glans penis/clitoridis. The injury to arteria dorsalis clitoridis leads to bleeding and/or hematoma. CONCLUSIONS Clinical anatomy of sulci is important in several situations in urologic surgery. It is possible to use sulcus nervi dorsalis penis/clitoridis for sexing of isolated pubis for anthropological or forensic purposes.


Immunology Letters | 2013

Regulatory T cells, dendritic cells and neutrophils in patients with renal cell carcinoma

I. Minárik; Jan Lašťovička; Vít Budinský; Jana Kayserova; Radek Spisek; L. Jarolim; Anna Fialová; M. Babjuk; Jiřina Bartůňková

We evaluated dendritic cells (DC), regulatory T lymphocytes (Treg) and neutrophils in 37 patients with newly diagnosed renal cell carcinoma (RCC) in the tumor and peripheral blood (PB) and correlated these parameters with tumor staging (early-T1, 2, late-T3, 4 and metastatic disease). The number of myeloid and plasmacytoid DC in blood of RCC patients was higher than in healthy controls. The percentage of myeloid dendritic cells (mDC) from CD45+ cells in tumors was higher in comparison with peripheral blood irrespective of disease stage. Higher percentage of these cells expressed a maturation marker in the periphery in the early stage (CD83 expressing cells). The number of plasmacytoid dendritic cells (pDC) in PB was similar in both early and late stage groups, but the early group displayed a significantly higher percentage of pDC in tumor cell suspension. Neutrophil counts in the peripheral blood of RCC patients were higher than in healthy controls, but the counts in both tumor stage groups were similar. The proportion of neutrophils from CD45+ cells was higher in late stage tumors. Higher percentage of Treg from CD4+ cells was detected in renal carcinoma tissue in comparison to PB with no difference between stages of the disease. Our results reflect the complex interplay between various cells of the immune system and the tumor microenvironment. Activation of dendritic cell subpopulations at early stages of the disease course is counterbalanced by the early appearance of T regulatory cells both in the periphery and tumor tissue. Later stages are characterized by the accumulation of neutrophils in the tumor. Appropriate timing of anticancer strategies, especially immunotherapy, should take these dynamics of the immune response in RCC patients into account.


European Urology | 2000

Causes and Treatment of Residual Urine Volume after Orthotopic Bladder Replacement in Women

L. Jarolim; M. Babjuk; S.M. Pecher; M. Grim; O. Naňka; M. Tichý; T. Hanus; M. Janský

Objectives: Intact innervation of the female urethra is conditional for normal urination. In the past, urethrectomy was performed as part of cystectomy. After intense anatomical studies of the female pelvis, urethral–function–sparing cystectomy was developed.Methods: Our clinical group consists of 41 female patients who were operated from 1993 to 1998 for bladder cancer, utilizing cystectomy with orthotopic bladder replacement.Results: In 28 patients, complete daytime continence was restored and in 13 patients, daytime continence was socially satisfactory (1–2 pads were used due to mild stress incontinence). The drawback of orthotopic replacements in females is the frequent development of serious residual volume, which was seen in onethird of the 41 patients. The functional results of orthotopic neobladders and therapy of residual urine volume were documented using urodynamic studies.Conclusions: Postvoiding residual volume may be caused by isolated dysfunction of the urethra and can be treated with clean intermittent self–catheterization or with α–blockers, which improve evacuation of the neobladder.


Scandinavian Journal of Urology and Nephrology | 2008

Influence of tumour-associated symptoms on the prognosis of patients with renal cell carcinoma

I. Kawaciuk; Lubomir Hyrsl; Pavel Dusek; L. Jarolim; M. Schmidt; Veronika Kaliska; Matus Chocholaty; Stepan Vesely

Objective. To evaluate the prognostic significance of symptoms related to renal cell carcinoma (RCC) in comparison with incidentally detected tumours in a group of long-term observed patients. Material and methods. The study included 396 patients operated for RCC between 1982 and 2001. The patients were classified according to age, gender, detection mode, pathological stage and grade, tumour size, nodal involvement and Eastern Cooperative Oncology Group (ECOG) performance status. Special attention was given to the analysis of duration and quality of symptoms. The endpoint of the study was overall survival, which was assessed with univariate and multivariate analyses using the Kaplan–Meier method, log-rank test and Cox proportional hazards model. Results. Of the 396 patients, 135 (34%) and 261 (66%) presented with incidental and symptomatic RCC, respectively. Compared with incidental cases, symptomatic tumours had significantly larger size (p<0.0001), and higher pathological stage (p<0.0001) and grade (p<0.02). Five-year survival in patients with incidental and symptomatic tumours was 88.1% and 59.4% (p<0.0001), respectively. In relation to the quality of symptoms, the 5-year survival in patients with local and systemic symptoms was 75.4% and 44.4% (p<0.0001), respectively. In the group of patients with a history of tumour-related symptoms shorter and longer than 3 months, the 5-year survival was 62.2% and 55.6% (p<0.0001), respectively. Multivariate analysis found tumour size [hazard ratio (HR) 1.22, p=0.05] tumour grade (HR 1.44, p=0.002), tumour stage (HR 1.35, p=0.001), presence of symptoms (HR 1.36, p=0.004) and ECOG (HR 1.25, p=0.005) to be independent prognostic variables. Conclusion: Preoperative somatic symptoms and performance status in patients with RCC provide readily available prognostic information in addition to tumour size, stage and grade.


Scandinavian Journal of Urology and Nephrology | 2017

Stratification model based on early postprostatectomy prostate-specific antigen kinetics may help to reduce the risk of overtreatment in candidates for adjuvant radiotherapy

Stepan Vesely; L. Jarolim; M. Schmidt; Joana Do Carmo Silva; Katerina Duskova; Marko Babjuk

Abstract Objective: The aim of this study was to construct a stratification model based on early postoperative kinetics of prostate-specific antigen (PSA) to select the most suitable high-risk patients for early intervention after radical prostatectomy (RP). Materials and methods: The study evaluated 205 men who had undergone RP without any adjuvant treatment. All of the patients had positive surgical margins, extracapsular extension and/or seminal vesicle invasion. The patients underwent multiple ultrasensitive PSA measurements on days 14, 30, 60 and 90 after RP, and subsequently at 3 month intervals. The ability of particular PSA measurements to predict biochemical recurrence (BCR) was assessed using the area under the curve (AUC). A sequential mathematical decision procedure was constructed to create a stratification model. Results: During the median follow-up of 45.9 months, 106 patients (51%) experienced BCR. Prediction of BCR in terms of the AUC for PSA measurements on days 14, 30, 60 and 90 after the surgery was 0.61, 0.70, 0.80 and 0.82, respectively. In the multivariate analysis, only PSA after RP remained as a predictor of progression-free survival (p < 0.001). The stratification model based on calculated cut-off values for PSA on day 30 (0.068 ng/ml) and PSA on day 60 (0.015 ng/ml) reduced the potential overtreatment rate by 37%. Conclusions: The results imply that ultrasensitive PSA values obtained very early after RP correlate with the presence of recurrent disease in high-risk patients. Incorporating these readily available variables into risk stratification models may help to individualize the administration of adjuvant radiotherapy and thus to minimize overtreatment.


Oncotarget | 2015

Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer.

Michal Podrazil; Rudolf Horvath; Etienne Becht; Daniela Rozkova; Pavla Bilkova; Klara Sochorova; Hana Hromadkova; Jana Kayserova; Katerina Vavrova; Jan Lastovicka; Petra Vrabcova; Katerina Kubackova; Zdenka Gašová; L. Jarolim; M. Babjuk; Radek Spisek; Jirina Bartunkova; Jitka Fucikova


European Urology | 2006

Sulcus Nervi Dorsalis Penis/Clitoridis: Anatomic Structure and Clinical Significance

Jiri Šedý; O. Naňka; Marta Belišová; Jon M. Walro; L. Jarolim


The Journal of Sexual Medicine | 2009

ORIGINAL RESEARCH—INTERSEX AND GENDER IDENTITY DISORDERS: Gender Reassignment Surgery in Male-to-Female Transsexualism: A Retrospective 3-Month Follow-up Study with Anatomical Remarks

L. Jarolim; Jiří Šedý; M. Schmidt; Ondřej Naňka; René Foltán; I. Kawaciuk

Collaboration


Dive into the L. Jarolim's collaboration.

Top Co-Authors

Avatar

M. Schmidt

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

M. Babjuk

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

I. Minárik

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Pavel Dusek

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Marko Babjuk

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Stepan Vesely

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

I. Kawaciuk

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Jiří Šedý

Academy of Sciences of the Czech Republic

View shared research outputs
Top Co-Authors

Avatar

M. Chocholatý

Charles University in Prague

View shared research outputs
Researchain Logo
Decentralizing Knowledge